Chemfab Alkalis
CHEMFAB NSE
Chemfab Alkalis
ChemicalsNSE: CHEMFAB BSE: 541269 Commodity Chemicals
Key Fundamentals
MicrocapCommodity ChemicalsChemicalsMarket Cap
₹541 Cr
Volatility
Moderate
P/E Ratio
-2,250.3
EBITDA
₹35.90 Cr
Return on Equity
-0.91%
Debt to Equity
0.34
Book Value
₹261.18
52W High
₹703
52W Low
₹290.35
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
4- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 11.5% over past five years.
- Company has a low return on equity of 1.02% over last 3 years.
- Earnings include an other income of Rs.9.41 Cr.
Growth Rate
Revenue Growth
-6.38% lower than
3Y
Net Income Growth
-50.72% higher than
3Y
Cash Flow Change
-4.56% lower than
3Y
ROE
-50.27% lower than
3Y
ROCE
57.28% higher than
3Y
EBITDA Margin (Avg.)
-24.58% higher than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 79.08 | 79.58 | 86.33 | 82.31 | 76.53 | 81.9 | 83.62 | 92.32 | 91.54 | 76.56 | 68.14 | 74.78 | 73.16 |
| Expenses | 63.59 | 68.7 | 71.13 | 69.98 | 68.2 | 71.75 | 71.71 | 78.98 | 80.24 | 71.1 | 66.21 | 66.26 | 63.03 |
| Operating Profit | 15.49 | 10.88 | 15.2 | 12.33 | 8.33 | 10.15 | 11.91 | 13.34 | 11.3 | 5.46 | 1.93 | 8.52 | 10.13 |
| OPM % | 19.59% | 13.67% | 17.61% | 14.98% | 10.88% | 12.39% | 14.24% | 14.45% | 12.34% | 7.13% | 2.83% | 11.39% | 13.85% |
| Other Income | 3.68 | 1.46 | 1.51 | 1.9 | 2.59 | 0.6 | 2.55 | -8.51 | 1.36 | 1.76 | 2.77 | 2.8 | 2.08 |
| Interest | 0.05 | 0.06 | 0.43 | 0.41 | 0.94 | 1.22 | 1.2 | 1.57 | 1.57 | 1.94 | 2.03 | 2.14 | 2.21 |
| Depreciation | 5.42 | 5.62 | 5.45 | 5.86 | 7.31 | 8.8 | 9.62 | 10.61 | 6.39 | 6.61 | 7.47 | 7.95 | 7.78 |
| PBT | 13.7 | 6.66 | 10.83 | 7.96 | 2.67 | 0.73 | 3.64 | -7.35 | 4.7 | -1.33 | -4.8 | 1.23 | 2.22 |
| Tax % | 30.58% | 35.44% | 34.35% | 32.04% | 66.67% | 172.6% | 48.08% | 25.03% | 45.74% | 51.13% | -7.08% | 60.16% | -158.11% |
| Net Profit | 9.51 | 4.3 | 7.1 | 5.41 | 0.9 | -0.53 | 1.88 | -9.19 | 2.55 | -2.01 | -4.45 | 0.48 | 5.73 |
| EPS in Rs | 6.7 | 3.03 | 4.99 | 3.8 | 0.63 | -0.37 | 1.32 | -6.4 | 1.78 | -1.4 | -3.1 | 0.33 | 3.99 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 205 | 181 | 272 | 331 | 327 | 334 | 311 | 293 |
| Expenses | 149 | 157 | 215 | 221 | 273 | 290 | 284 | 267 |
| Operating Profit | 55 | 24 | 57 | 111 | 55 | 44 | 27 | 26 |
| OPM % | 27% | 13% | 21% | 33% | 17% | 13% | 9% | 9% |
| Other Income | 0 | 1 | 6 | 2 | 9 | -3 | 9 | 9 |
| Interest | 4 | 3 | 1 | 1 | 2 | 6 | 8 | 8 |
| Depreciation | 25 | 20 | 22 | 23 | 22 | 36 | 28 | 30 |
| PBT | 27 | 2 | 39 | 89 | 39 | 0 | 0 | -3 |
| Tax % | 5% | 500% | 26% | 28% | 33% | 2210% | 1615% | — |
| Net Profit | 25 | -8 | 29 | 65 | 26 | -7 | -3 | 0 |
| EPS in Rs | 18.26 | -5.78 | 20.34 | 45.54 | 18.5 | -4.83 | -2.39 | -0.18 |
| Div. Payout % | 7% | 0% | 6% | 3% | 7% | -26% | -52% | — |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 262 | 253 | 284 | 347 | 373 | 366 | 361 |
| Borrowings | 43 | 32 | 9 | 2 | 20 | 84 | 126 |
| Other Liabilities | 30 | 36 | 46 | 48 | 93 | 57 | 76 |
| Total Liabilities | 348 | 335 | 352 | 412 | 500 | 522 | 577 |
| Fixed Assets | 195 | 202 | 194 | 192 | 247 | 317 | 387 |
| CWIP | 35 | 3 | 8 | 31 | 74 | 36 | 31 |
| Investments | 1 | 24 | 31 | 68 | 5 | 16 | 14 |
| Other Assets | 118 | 105 | 119 | 121 | 174 | 152 | 146 |
| Total Assets | 348 | 335 | 352 | 412 | 500 | 522 | 577 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 54 | 45 | 55 | 93 | 31 | 40 | 38 |
| Investing | -58 | -6 | -21 | -48 | -110 | -86 | -81 |
| Financing | 3 | -16 | -25 | -9 | 16 | 59 | 31 |
| Net Cash Flow | -1 | 23 | 9 | 36 | -62 | 13 | -12 |
| Free Cash Flow | -4 | 38 | 35 | 40 | -60 | -71 | -38 |
| CFO/OP | 110 | 157 | 107 | 97 | 74 | 104 | 142 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 31 | 29 | 24 | 24 | 23 | 28 |
| Inventory Days | 84 | 79 | 54 | 89 | 60 | 100 | 92 |
| Days Payable | 165 | 154 | 92 | 145 | 101 | 118 | 111 |
| Cash Conversion Cycle | -63 | -45 | -9 | -32 | -18 | 4 | 9 |
| Working Capital Days | -2 | 15 | 5 | 7 | -24 | 28 | -1 |
| ROCE % | — | 2% | 13% | 28% | 10% | 3% | 1% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Chemfab Alkalis insights
59 extracted metrics + investor summaries across FY10–FY27.
Documents
1
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
11 Sep - Chemfab AGM resolutions passed on 9 September 2026, including ₹1.25 dividend and auditor appointment. 11 Sep - Chemfab AGM resolutions passed on 9 September 2026, including ₹1.25 dividend and auditor appointment.
2
Board Meeting Intimation for Approval Of The Audited Financial Statements For The Quarter And Year Ended 31St March 2026 And To Consider Declaration Of Dividend, If Any.
7 May - Board meets 13 May 2026 to approve FY26 audited results and consider dividend; trading window closed till 15 May. 7 May - Board meets 13 May 2026 to approve FY26 audited results and consider dividend; trading window closed till 15 May.
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - Submission of certificate under Reg 74(5) received from Cameo Corporate Services Ltd for the qtr ended 31st March 2026 8 Apr - Submission of certificate under Reg 74(5) received from Cameo Corporate Services Ltd for the qtr ended 31st March 2026
4
Closure of Trading Window
25 Mar - Trading window closed from 01-Apr-2026 until 48 hours after audited results for quarter/year ended 31-Mar-2026. 25 Mar - Trading window closed from 01-Apr-2026 until 48 hours after audited results for quarter/year ended 31-Mar-2026.
5
Announcement under Regulation 30 (LODR)-Credit Rating
14 Mar - Ind‑Ra downgraded bank loans to IND BBB+/Negative; INR1,673m downgraded, assigned 13 Mar 2026. 14 Mar - Ind‑Ra downgraded bank loans to IND BBB+/Negative; INR1,673m downgraded, assigned 13 Mar 2026.
Frequently Asked Questions about Chemfab Alkalis
What does Chemfab Alkalis Ltd do?
Incorproated in 2009, Chemfab
Alkalis Ltd manufactures basic
inorganic chemicals and PVCO
pipes[1]
Where is Chemfab Alkalis Ltd (CHEMFAB) listed?
Chemfab Alkalis Ltd trades as CHEMFAB on the NSE and under code 541269 on the BSE.
Which sector does Chemfab Alkalis Ltd belong to?
Chemfab Alkalis Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the market capitalisation of Chemfab Alkalis Ltd?
Chemfab Alkalis Ltd has a market capitalisation of ₹540.52 Cr, which places it in the Small Cap band.
What is the PE ratio of Chemfab Alkalis Ltd?
Chemfab Alkalis Ltd trades at a PE ratio of -2250.30, against a book value of ₹261.18 per share.
What is the 52-week high and low of Chemfab Alkalis Ltd?
Over the last 52 weeks Chemfab Alkalis Ltd has traded between ₹290.35 and ₹703.
Does Chemfab Alkalis Ltd pay dividends?
Chemfab Alkalis Ltd has a dividend yield of 0.33%.
What is the Return on Equity (ROE) of Chemfab Alkalis Ltd?
Chemfab Alkalis Ltd reported a return on equity of -0.91%. Its debt-to-equity ratio is 0.34.
Company Information
Incorproated in 2009, Chemfab Alkalis Ltd manufactures basic inorganic chemicals and PVCO pipes[1]
Website chemfabalkalis.com
CEO Mr. Suresh Krishnamurthi Rao
Employees 213
Listed 2018-04-25
Face Value ₹ 10
Issued Size 1,43,73,702
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CHEMFAB.md for Chemfab Alkalis Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.